Supreme Court asked to pause ruling blocking telehealth and mail access to abortion pills

Danco Laboratories, one of makers of the mifepristone abortion pill on Saturday asked the Supreme Court to pause a lower court ruling that imposed a nationwide requirement for the medication to be dispensed in-person.

Danco Laboratories, one of the makers of the abortion pill mifepristone, asked the Supreme Court on Saturday to block a lower court ruling that imposed a nationwide requirement for the medication to be dispensed in person.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

In its filing, the drugmaker also asked the high court to grant an immediate pause of the lower court’s ruling while the Supreme Court considers the appeal.

“Danco has been free to rely on the procedures set by FDA to distribute its product. The Fifth Circuit’s decision immediately ends that. A stay should issue to prevent the disruption and confusion that will result if the decision below were to remain operative,” lawyers for the company wrote in their filing.